AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Apr 23, 2021
30442_dirs_2021-04-23_1259a8c4-976c-4e6a-b66a-c70b83d08d05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-04-21
Reporting Person: Medpace Investors, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-04-21 | Common Stock | S | 15687 | $187.02 | Disposed | 6362903 | Direct |
| 2021-04-22 | Common Stock | S | 14377 | $188.64 | Disposed | 6348526 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $182.95 to $189.39. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $185.25 to $191.62. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.